{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:12:56Z","timestamp":1762377176601,"version":"3.44.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.lfs.2022.120662","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T21:07:06Z","timestamp":1653685626000},"page":"120662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Autophagy modulation by irbesartan mitigates the pulmonary fibrotic alterations in bleomycin challenged rats: Comparative study with rapamycin"],"prefix":"10.1016","volume":"303","author":[{"given":"Hadeer A.","family":"Alsayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1349-5300","authenticated-orcid":false,"given":"Hala M.F.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherine M.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed K.","family":"El-Kherbetawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samah M.","family":"Elaidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120662_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/cells8020123","article-title":"Protective features of autophagy in pulmonary infection and inflammatory diseases","volume":"8","author":"Wang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2022.120662_bb0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/09031936.00217614","article-title":"Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry","volume":"46","author":"Behr","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2022.120662_bb0015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S2213-2600(15)00093-4","article-title":"Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials","volume":"3","author":"Durheim","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2022.120662_bb0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/thoraxjnl-2016-208819","article-title":"Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis","volume":"72","author":"Kreuter","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2022.120662_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay3724","article-title":"Targeted inhibition of PI3 kinase\/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models","volume":"12","author":"Hettiarachchi","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2022.120662_bb0030","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/ijms19030778","article-title":"The role of the mammalian target of rapamycin (mTOR) in pulmonary fibrosis","volume":"19","author":"Lawrence","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120662_bb0035","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/EBC20170027","article-title":"mTORC1 as the main gateway to autophagy","volume":"61","author":"Rabanal-Ruiz","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.lfs.2022.120662_bb0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/food.19780220307","article-title":"Einflu\u00df einer reduzierten Ern\u00e4hrung und k\u00f6rperlichen Belastung auf die Leberlysosomen. Morphologische und biochemische Untersuchungen","volume":"22","author":"Krustev","year":"1978","journal-title":"Food Nahr."},{"key":"10.1016\/j.lfs.2022.120662_bb0045","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1164\/rccm.201512-2468SO","article-title":"Autophagy in pulmonary diseases","volume":"194","author":"Nakahira","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2022.120662_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4701275","article-title":"Till death do us part: the marriage of autophagy and apoptosis","volume":"2018","author":"Cooper","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2022.120662_bb0055","first-page":"1","article-title":"Overview of the minireviews on autophagy","volume":"41","author":"Lee","year":"2018","journal-title":"Mol. Cells"},{"key":"10.1016\/j.lfs.2022.120662_bb0060","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1038\/s41467-018-07338-z","article-title":"Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of yap","volume":"9","author":"Lee","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2022.120662_bb0065","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1599207","article-title":"Autophagy: process and function","volume":"21","author":"Mizushima","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.lfs.2022.120662_bb0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ceb.2009.11.014","article-title":"Mammalian autophagy: core molecular machinery and signaling regulation","volume":"22","author":"Yang","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.lfs.2022.120662_bb0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-pharmtox-010716-104936","article-title":"Autophagy: a druggable process","volume":"57","author":"Morel","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2022.120662_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.devcel.2017.02.016","article-title":"Cleaning house: selective autophagy of organelles","volume":"41","author":"Anding","year":"2017","journal-title":"Dev. Cell"},{"key":"10.1016\/j.lfs.2022.120662_bb0085","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acs.jmedchem.6b00935","article-title":"Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets","volume":"60","author":"Liu","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2022.120662_bb0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ddstr.2006.09.003","article-title":"Strategies targeting fibrosis in pulmonary disease","volume":"3","author":"Ask","year":"2006","journal-title":"Drug Discov. Today Ther. Strateg."},{"key":"10.1016\/j.lfs.2022.120662_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12890-018-0626-4","article-title":"Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells","volume":"18","author":"Molina-Molina","year":"2018","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.lfs.2022.120662_bb0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.14.1.483","article-title":"Immunopharmacology of rapamycin","volume":"14","author":"Abraham","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lfs.2022.120662_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/cancers10010023","article-title":"mTOR cross-talk in cancer and potential for combination therapy","volume":"10","author":"Conciatori","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2022.120662_bb0110","series-title":"Vasc. Anom","first-page":"31","article-title":"Sirolimus for the treatment of vascular anomalies","author":"Mack","year":"2020"},{"key":"10.1016\/j.lfs.2022.120662_bb0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1631\/jzus.B1400229","article-title":"Effects of rapamycin against paraquat-induced pulmonary fibrosis in mice","volume":"16","author":"Shao","year":"2015","journal-title":"J. Zhejiang Univ.-Sci. B."},{"key":"10.1016\/j.lfs.2022.120662_bb0120","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2165\/00003495-200868110-00008","article-title":"Irbesartan: a review of its use in hypertension and diabetic nephropathy","volume":"68","author":"Croom","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2022.120662_bb0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.resinv.2012.12.005","article-title":"Preventive effect of irbesartan on bleomycin-induced lung injury in mice","volume":"51","author":"Tanaka","year":"2013","journal-title":"Respir. Investig."},{"key":"10.1016\/j.lfs.2022.120662_bb0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.9790\/3013-034203847","article-title":"Role of irbesartan in protection against pulmonary toxicity induced by bleomycin in rats","volume":"3","author":"El-Gamal","year":"2013","journal-title":"IOSR J. Pharm. IOSRPHR"},{"key":"10.1016\/j.lfs.2022.120662_bb0135","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bjp.0705785","article-title":"Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1: suppression of T-cell activation by irbesartan","volume":"142","author":"Cheng","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120662_bb0140","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.3390\/ijms21093341","article-title":"Therapeutic effect of rapamycin on aortic dissection in mice","volume":"21","author":"Hayashi-Hori","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120662_bb0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.25011\/cim.v34i6.15894","article-title":"Anti-inflammatory and anti-fibrotic effects of sirolimus on bleomycin-induced pulmonary fibrosis in rats","volume":"34","author":"Tulek","year":"2011","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.lfs.2022.120662_bb0150","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.3390\/ijms21134735","article-title":"Nintedanib reduces neutrophil chemotaxis via activating GRK2 in bleomycin-induced pulmonary fibrosis","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120662_bb0155","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/thorax.58.9.765","article-title":"Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats","volume":"58","author":"Dik","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2022.120662_bb0160","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1157\/13109471","article-title":"Experimental models for the study of pulmonary fibrosis: current usefulness and future promise","volume":"43","author":"Molina-Molina","year":"2007","journal-title":"Arch. Bronconeumol. Engl. Ed."},{"key":"10.1016\/j.lfs.2022.120662_bb0165","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejphar.2008.06.046","article-title":"Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis","volume":"590","author":"Oku","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120662_bb0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1183\/09031936.05.00049704","article-title":"Effect of rosiglitazone and 15-deoxy- 12,14-prostaglandin J2 on bleomycin-induced lung injury","volume":"25","author":"Genovese","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2022.120662_bb0175","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.lfs.2022.120662_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193057","article-title":"A fully automated image analysis method to quantify lung fibrosis in the bleomycin-induced rat model","volume":"13","author":"Seger","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.lfs.2022.120662_bb0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejphar.2006.03.011","article-title":"Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats","volume":"536","author":"Chen","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120662_bb0190","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: technique, theory, and trouble shooting","volume":"4","author":"Yang","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.lfs.2022.120662_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138625","article-title":"mTOR overactivation and compromised autophagy in the pathogenesis of pulmonary fibrosis","volume":"10","author":"Gui","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.lfs.2022.120662_bb0200","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41419-019-1820-x","article-title":"Autophagy inhibition-mediated epithelial\u2013mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis","volume":"10","author":"Hill","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2022.120662_bb0205","doi-asserted-by":"crossref","first-page":"L552","DOI":"10.1152\/ajplung.00079.2015","article-title":"Reduced FoxO3a expression causes low autophagy in idiopathic pulmonary fibrosis fibroblasts on collagen matrices","volume":"309","author":"Im","year":"2015","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.lfs.2022.120662_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041394","article-title":"Autophagy in idiopathic pulmonary fibrosis","volume":"7","author":"Patel","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lfs.2022.120662_bb0215","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.27498","article-title":"Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis","volume":"62","author":"Yoshizaki","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2022.120662_bb0220","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3892\/etm.2015.2885","article-title":"Apigenin protects against bleomycin-induced lung fibrosis in rats","volume":"11","author":"Chen","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2022.120662_bb0225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1165\/rcmb.2007-0340OC","article-title":"Male sex hormones exacerbate lung function impairment after bleomycin-induced pulmonary fibrosis","volume":"39","author":"Voltz","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2022.120662_bb0230","doi-asserted-by":"crossref","first-page":"L510","DOI":"10.1152\/ajplung.00122.2011","article-title":"Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis","volume":"301","author":"Redente","year":"2011","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.lfs.2022.120662_bb0235","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/ki.2010.324","article-title":"The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantation","volume":"78","author":"Geissler","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2022.120662_bb0240","first-page":"380","article-title":"The protective and therapeutic effects of total flavonoids of astragalus against bleomycin-induced pulmonary fibrosis are through the enhancement of autophagy","volume":"5","author":"Xu","year":"2018","journal-title":"J. Tradit. Chin. Med. Sci."},{"key":"10.1016\/j.lfs.2022.120662_bb0245","article-title":"Autophagy in pulmonary fibrosis: friend or foe?","author":"Hill","year":"2021","journal-title":"Genes Dis."},{"key":"10.1016\/j.lfs.2022.120662_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.607483","article-title":"The epithelial-to-mesenchymal transition as a possible therapeutic target in fibrotic disorders","volume":"8","author":"Di Gregorio","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2022.120662_bb0255","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor \u03b2 in tissue fibrosis","volume":"331","author":"Epstein","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2022.120662_bb0260","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3349\/ymj.2013.54.2.437","article-title":"Rapamycin inhibits transforming growth factor \u03b21-induced fibrogenesis in primary human lung fibroblasts","volume":"54","author":"Gao","year":"2013","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.lfs.2022.120662_bb0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1165\/rcmb.2019-0071OC","article-title":"PAI-1 regulation of TGF-\u03b21\u2013induced alveolar type II cell senescence, SASP secretion, and SASP-mediated activation of alveolar macrophages","volume":"62","author":"Rana","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2022.120662_bb0270","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.3390\/ijms19082460","article-title":"TGF-\u03b2 signaling in lung health and disease","volume":"19","author":"Saito","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120662_bb0275","article-title":"Evaluation of the antifibrotic effect of serotonin receptor antagonists on bleomycin induced pulmonary fibrosis in rats","volume":"7","author":"Abd-Alla","year":"2017","journal-title":"Egypt. J. Basic Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120662_bb0280","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejphar.2012.05.026","article-title":"Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats","volume":"689","author":"Samah","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120662_bb0285","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1159\/000430131","article-title":"Angiotensin-converting enzyme 2 attenuates bleomycin-induced lung fibrosis in mice","volume":"36","author":"Wang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2022.120662_bb0290","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/hdi.12436","article-title":"Long-term effects of angiotensin II blockade with irbesartan on inflammatory markers in hemodialysis patients: a randomized double blind placebo controlled trial (SAFIR study): irbesartan and markers of inflammation","volume":"21","author":"Peters","year":"2017","journal-title":"Hemodial. Int."},{"key":"10.1016\/j.lfs.2022.120662_bb0295","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11596-010-0109-1","article-title":"Effects and mechanism of irbesartan on tubulointerstitial fibrosis in 5\/6 nephrectomized rats","volume":"30","author":"Zhao","year":"2010","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"key":"10.1016\/j.lfs.2022.120662_bb0300","doi-asserted-by":"crossref","DOI":"10.2174\/157340810791233033","article-title":"TGF-\u03b2: titan of lung fibrogenesis","volume":"6","author":"Yue","year":"2010","journal-title":"Curr. Enzym. Inhib."},{"key":"10.1016\/j.lfs.2022.120662_bb0305","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.jas.2011.07.022","article-title":"Fish bone chemistry and ultrastructure: implications for taphonomy and stable isotope analysis","volume":"38","author":"Szpak","year":"2011","journal-title":"J. Archaeol. Sci."},{"key":"10.1016\/j.lfs.2022.120662_bb0310","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1007\/s00018-021-03841-7","article-title":"Role and mechanisms of autophagy in lung metabolism and repair","volume":"78","author":"Li","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2022.120662_bb0315","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1165\/rcmb.2019-0255OC","article-title":"Active mTOR in lung epithelium promotes epithelial-mesenchymal transition and enhances lung fibrosis","volume":"62","author":"Saito","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2022.120662_bb0320","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fcell.2019.00192","article-title":"Pleiotropic Effects of mTOR and Autophagy During Development and Aging","volume":"7","author":"Kathrin","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2022.120662_bb0325","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/acel.12514","article-title":"mTORC 1 activation decreases autophagy in aging and idiopathic pulmonary fibrosis and contributes to apoptosis resistance in IPF fibroblasts","volume":"15","author":"Romero","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.lfs.2022.120662_bb0330","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1139\/cjpp-2018-0259","article-title":"Protective effect of irbesartan against doxorubicin-induced nephrotoxicity in rats: implication of AMPK, PI3K\/Akt, and mTOR signaling pathways","volume":"96","author":"Mohamed","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120662_bb0335","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.intimp.2016.11.015","article-title":"Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db\/db mice via stimulating PPAR-\u03b3, AMPK\/Akt\/mTOR signaling and autophagy","volume":"42","author":"Zhong","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2022.120662_bb0340","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41374-018-0160-2","article-title":"Lipopolysaccharide promotes lung fibroblast proliferation through autophagy inhibition via activation of the PI3K-akt-mTOR pathway","volume":"99","author":"Xie","year":"2019","journal-title":"Lab. Investig."},{"key":"10.1016\/j.lfs.2022.120662_bb0345","article-title":"Erratum: emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease","volume":"16","author":"Mora","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2022.120662_bb0350","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cell.2014.02.049","article-title":"To be or not to be? How selective autophagy and cell death govern cell fate","volume":"157","author":"Green","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2022.120662_bb0355","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1042\/EBC20170021","article-title":"The mammalian ULK1 complex and autophagy initiation","volume":"61","author":"Zachari","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.lfs.2022.120662_bb0360","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181822","article-title":"Rapamycin inhibits proliferation and induces autophagy in human neuroblastoma cells","volume":"38","author":"Lin","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.lfs.2022.120662_bb0365","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","article-title":"Metformin reverses established lung fibrosis in a bleomycin model","volume":"24","author":"Rangarajan","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2022.120662_bb0370","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2018.9586","article-title":"Rapamycin induces autophagy to alleviate acute kidney injury following cerebral ischemia and reperfusion via the mTORC1\/ATG13\/ULK1 signaling pathway","author":"Su","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2022.120662_bb0375","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3760\/cma.j.issn.0366-6999.20132749","article-title":"Rapamycin attenuates bleomycin-induced pulmonary fibrosis in rats and the expression of metalloproteinase-9 and tissue inhibitors of metalloproteinase-1 in lung tissue","volume":"127","author":"Jin","year":"2014","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.lfs.2022.120662_bb0380","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.pharep.2016.08.005","article-title":"The antifibrotic effects of alveolar macrophages 5-HT2C receptors blockade on bleomycin-induced pulmonary fibrosis in rats","volume":"68","author":"Elaidy","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2022.120662_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/7601393","article-title":"The protective effect of naringin against bleomycin-induced pulmonary fibrosis in wistar rats","volume":"2016","author":"Turgut","year":"2016","journal-title":"Pulm. Med."},{"key":"10.1016\/j.lfs.2022.120662_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/921724","article-title":"Evaluating the ameliorative potential of quercetin against the bleomycin-induced pulmonary fibrosis in wistar rats","volume":"2013","author":"Verma","year":"2013","journal-title":"Pulm. Med."},{"key":"10.1016\/j.lfs.2022.120662_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/7947596","article-title":"Elevation of IL-6 and IL-33 levels in serum associated with lung fibrosis and skeletal muscle wasting in a bleomycin-induced lung injury mouse model","volume":"2019","author":"Shieh","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.lfs.2022.120662_bb0400","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1165\/rcmb.2008-0377OC","article-title":"Rapamycin prevents transforming growth factor-\u03b1\u2013Induced pulmonary fibrosis","volume":"41","author":"Korfhagen","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2022.120662_bb0405","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.520","article-title":"Koschei the immortal and anti-aging drugs","volume":"5","author":"Blagosklonny","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2022.120662_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/653524","article-title":"Rapamycin regulates bleomycin-induced lung damage in SP-C-deficient mice","volume":"2011","author":"Madala","year":"2011","journal-title":"Pulm. Med."},{"key":"10.1016\/j.lfs.2022.120662_bb0415","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12931-017-0600-3","article-title":"Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy","volume":"18","author":"Kurita","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.lfs.2022.120662_bb0420","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/cells9030775","article-title":"Pirfenidone inhibits cell proliferation and collagen I production of primary human intestinal fibroblasts","volume":"9","author":"Cui","year":"2020","journal-title":"Cells"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522003629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522003629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:59:25Z","timestamp":1758401965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522003629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":84,"alternative-id":["S0024320522003629"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120662","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autophagy modulation by irbesartan mitigates the pulmonary fibrotic alterations in bleomycin challenged rats: Comparative study with rapamycin","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120662"}}